Cooperative Agreement AID492A1200014

The U.S. Agency for International Development (USAID) has awarded a $6,480,574 Cooperative Agreement to Tropical Disease Foundation Inc. (TDF) under the USAID Foreign Assistance for Programs Overseas (CFDA 98.001) program. The award, titled "TUBERCULOSIS-FREE VISAYAS AND MINDANAO," will run from January 2025 to January 2030 and aims to control and prevent the spread of tuberculosis in the Philippines. As the primary awardee, TDF will leverage its expertise in infectious disease...

Federal Project Grant Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $743,651 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The Regents of the University of California, San Francisco, effective August 1, 2025, through July 31, 2030. The project focuses on developing and validating plasma cell-free RNA (cfRNA) biomarkers for tuberculosis diagnosis and treatment monitoring. The research team will conduct diagnostic...

This $7,352,643 federal Project Grant award, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports efforts by The Global Alliance For TB Drug Development Inc. (TB Alliance) to accelerate the development of new tuberculosis (TB) drugs and treatment regimens. The grant, awarded on September 30, 2024 with a completion date of September 29, 2028, will fund TB Alliance's research on innovative, host-directed approaches to target...

Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded Massachusetts General Hospital a $798,107 Project Grant on February 3, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to conduct tissue-based research examining tuberculosis-associated lung fibrosis and post-TB lung disease (PTLD). The grant, with a completion date of January 31, 2031, supports a collaborative investigation leveraging both a human lung...

Federal Project Grant Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded Indiana University Indianapolis a Project Grant of $2.27 million under the Allergy and Infectious Diseases Research program (CFDA 93.855) on August 22, 2025, to conduct a five-year research initiative examining post-tuberculosis lung disease (PTLD) in youth aged 15–24 globally. The project leverages the Tuberculosis Sentinel Research Network (TB-SRN), a prospective cohort study within the...

The U.S. Agency for International Development (USAID) awarded a $6,925,000 Cooperative Agreement under the USAID Foreign Assistance for Programs Overseas (CFDA 98.001) program to University Research Co., LLC to implement the "TB-FREE LUZON ACTIVITY" in the Philippines. The five-year project, with a start date of September 26, 2024 and a completion date of September 25, 2029, aims to strengthen tuberculosis (TB) prevention and control services in the Luzon region of the Philippines....

National Jewish Health received a $429,546 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) to evaluate antibiotic regimen efficacy for tuberculosis (TB) treatment. The award, effective August 8, 2025, through July 31, 2027, supports research utilizing SEARCH-TB, an RNA-sequencing platform designed to quantify drug-induced bacterial injury and physiological adaptations in Mycobacterium...

The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $238,500 Project Grant under the Allergy and Infectious Diseases Research (CFDA 93.855) federal grant program to the University of California, San Diego (UCSD) to develop a novel electrochemical lateral flow assay (ELFA) for diagnosing tuberculosis (TB) from a single drop of blood. The objective is to create a highly sensitive and specific point-of-need TB detection test that can accurately distinguish active TB from...

Federal Project Grant Award Summary Albert Einstein College of Medicine received an $850,711 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded on August 1, 2025, with a completion date of July 31, 2030. The grant supports research to develop non-sputum-based point-of-care tests (POCTs) for tuberculosis (TB) detection in resource-limited settings, addressing a World Health...

Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded Boston Children's Hospital $489,500 under the Allergy and Infectious Diseases Research program (CFDA 93.855) to develop innovative human cellular models for studying tuberculosis (TB) infection and innate immune responses. The award, effective August 1, 2025, through July 31, 2027, funds the establishment of a physiological in vitro lung alveolar epithelial cell organoid model derived...